A detailed history of Nuveen Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 17,563,860 shares of PFE stock, worth $491 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
17,563,860
Previous 17,869,787 1.71%
Holding current value
$491 Million
Previous $514 Million 5.26%
% of portfolio
0.15%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $7.92 Million - $9.1 Million
-305,927 Reduced 1.71%
17,563,860 $487 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $33.2 Million - $43.2 Million
1,272,415 Added 7.67%
17,869,787 $514 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $65.5 Million - $76.6 Million
-2,041,936 Reduced 10.95%
16,597,372 $551 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $9.46 Million - $10.9 Million
-261,776 Reduced 1.38%
18,639,308 $684 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $20.5 Million - $26.7 Million
-521,412 Reduced 2.68%
18,901,084 $771 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $19.4 Million - $25.3 Million
-464,981 Reduced 2.34%
19,422,496 $995 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $32.5 Million - $39.6 Million
-742,023 Reduced 3.6%
19,887,477 $870 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $629,457 - $746,339
13,528 Added 0.07%
20,629,500 $1.08 Billion
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $342 Million - $424 Million
-7,470,695 Reduced 26.6%
20,615,972 $1.12 Billion
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $173 Million - $256 Million
4,177,367 Added 17.47%
28,086,667 $1.66 Billion
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $24.7 Million - $31.8 Million
-630,258 Reduced 2.57%
23,909,300 $1.03 Billion
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $10.8 Million - $12.3 Million
-301,412 Reduced 1.21%
24,539,558 $961 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $194 Million - $219 Million
-5,790,407 Reduced 18.9%
24,840,970 $900 Million
Q4 2020

May 17, 2021

BUY
$33.47 - $42.56 $64.2 Million - $81.6 Million
1,917,584 Added 6.68%
30,631,377 $1.13 Billion
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $65.4 Million - $83.1 Million
-1,952,686 Reduced 6.37%
28,713,793 $1.06 Billion
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $39 Million - $45.7 Million
-1,228,173 Reduced 3.85%
30,666,479 $1.13 Billion
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $267 Million - $324 Million
-8,858,775 Reduced 21.74%
31,894,652 $1.04 Billion
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $260 Million - $372 Million
9,624,759 Added 30.92%
40,753,427 $1.26 Billion
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $5.91 Million - $6.7 Million
179,434 Added 0.58%
31,128,668 $1.22 Billion
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $167 Million - $216 Million
-5,137,020 Reduced 14.24%
30,949,234 $1.11 Billion
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $1.28 Billion - $1.43 Billion
34,544,423 Added 2240.48%
36,086,254 $1.56 Billion
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $11.6 Million - $12.8 Million
-310,128 Reduced 16.75%
1,541,831 $65.5 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $8.83 Million - $10.1 Million
-229,506 Reduced 11.03%
1,851,959 $80.8 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $317,951 - $385,655
-9,224 Reduced 0.44%
2,081,465 $91.7 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $200,584 - $213,843
-6,082 Reduced 0.29%
2,090,689 $75.9 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $8.88 Million - $10.3 Million
278,415 Added 15.31%
2,096,771 $74.4 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $4.04 Million - $4.29 Million
121,469 Added 7.16%
1,818,356 $0
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $52.6 Million - $57.9 Million
1,696,887
1,696,887 $60.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.